Quest Diagnostics (FRA:QDI) YoY EBITDA Growth : 1.72% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Quest Diagnostics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Quest Diagnostics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 1.72%.

Quest Diagnostics's EBITDA per Share for the three months ended in Mar. 2024 was €3.54.

Quest Diagnostics YoY EBITDA Growth Historical Data

The historical data trend for Quest Diagnostics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics YoY EBITDA Growth Chart

Quest Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

18.13

38.93

49.89

-33.34

-3.47

Quest Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-22.06	1.85	-12.67	49.86	1.72

Quest Diagnostics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Quest Diagnostics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(14.055	-	14.56)	/	\| 14.56 \|
=	-3.47 %

Quest Diagnostics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(3.54	-	3.48)	/	\| 3.48 \|
=	1.72 %

Quest Diagnostics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Diagnostics (FRA:QDI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (FRA:QDI) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

DGX:USA

Address

500 Plaza Drive, Secaucus, NJ, USA, 07094

Website

https://www.questdiagnostics.com

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (FRA:QDI) Headlines

No Headlines